awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37506507-3332C1EF-E05F-4354-AEA4-0B00B16BC413
Q37506507-3332C1EF-E05F-4354-AEA4-0B00B16BC413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37506507-3332C1EF-E05F-4354-AEA4-0B00B16BC413
Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?
P2860
Q37506507-3332C1EF-E05F-4354-AEA4-0B00B16BC413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37506507-3332C1EF-E05F-4354-AEA4-0B00B16BC413
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
13ea2aecc501d6230584fe3964c4d2a844c3a4e3
P2860
Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism.